VRAX vs ZVSA
Comparison between Virax Biolabs Group Ltd - Class A (VRAX, Company) and ZyVersa Therapeutics Inc (ZVSA, Company).
Both VRAX and ZVSA are from the Healthcare sector.
VRAX vs ZVSA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
VRAX
$1.52M
ZVSA
$1.43M
Max Drawdown
Winner
VRAX
99.95%
ZVSA
100.00%
Sharpe Ratio
VRAX
-0.51
Winner
ZVSA
-0.18
5Y Beta
VRAX
1.07
ZVSA
N/A
Industry
VRAX
Biotechnology
ZVSA
Biotechnology
P/E Ratio
Winner
VRAX
-0.08
ZVSA
-0.06
Debt to Equity
VRAX
10.13%
Winner
ZVSA
0.00%
P/S Ratio
VRAX
793.06
ZVSA
N/A
P/B Ratio
VRAX
0.42
ZVSA
N/A
VRAX vs ZVSA - Historical Returns
Returns include dividend reinvestment.
1M
VRAX
-40.53%
Winner
ZVSA
-19.92%
3M
Winner
VRAX
-27.03%
ZVSA
-27.27%
6M
VRAX
-63.50%
Winner
ZVSA
+19.40%
1Y
VRAX
-82.24%
Winner
ZVSA
-77.46%
Max(CAGR)
Winner
VRAX
-84.03%
ZVSA
-95.30%
VRAX vs ZVSA - Annual Returns (2022 - 2026)
Returns include dividend reinvestment.
| Year | VRAX | ZVSA |
|---|---|---|
| 2026 | -64.84% | +18.96% |
| 2025 | -84.35% | -87.74% |
| 2024 | +64.23% | -87.95% |
| 2023 | -81.82% | -98.51% |
| 2022 | -95.99% | -93.02% |
VRAX vs ZVSA Drawdown Comparison
The maximum drawdown for VRAX was -99.95%, occurring on Apr 10, 2026. This drawdown has not yet recovered.
The maximum drawdown for ZVSA was -100.00%, occurring on Aug 29, 2025. This drawdown has not yet recovered.
The current VRAX drawdown is -99.94%. The current ZVSA drawdown is -100.00%.
| Rank | VRAX | ZVSA |
|---|---|---|
| #1 | -99.95% Jul 28, 2022 - Apr 10, 2026 | -100.00% Dec 12, 2022 - Aug 29, 2025 |
| #2 | -43.19% Jul 21, 2022 - Jul 26, 2022 | N/A |
Correlation
Correlation between VRAX and ZVSA is 0.85 which considered as a strong positive correlation - the stocks tend to move together.
0.85
-101
Select Stocks to Compare
Popular: VRAX vs SPYZVSA vs SPY
More Comparisons
Compare with similar stocks